CVRx (CVRX) vs Myomo (MYO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Myomo (MYO) has outperformed CVRx (CVRX) over the past year, gaining 23.3% versus a loss of 82.8%. Over five years, MYO leads with a -89.3% price change compared with -89.9% for CVRX. Myomo is the larger company by market cap ($56.6 million vs $42.1 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVRX | MYO |
|---|---|---|
| Share price | $1.58 | $1.43 |
| Market cap | $42.09M | $56.64M |
| 1-day change | -5.95% | +1.42% |
| YTD return | -77.75% | +57.14% |
| 1-year return | -82.75% | +23.28% |
| 5-year return | -89.91% | -89.28% |
| EPS (TTM) | $-1.88 | $-0.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.30 | $1.89 |
| 52-week low | $1.50 | $0.605 |
| Distance from 52-week high | -86.02% | -24.14% |
| Analyst consensus | none | none |
| Avg. price target upside | +189.87% | +224.48% |
| Average volume | 922.12K | 496.01K |
| Shares outstanding | 26.64M | 39.61M |
| Employees | 223 | 194 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MYO has outperformed CVRX by 106.0 percentage points over the past year.
About CVRx
CVRX stock →CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
Health Care · Medical/Dental Instruments · 223 employees
About Myomo
MYO stock →Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Health Care · Industrial Specialties · 194 employees
CVRX vs MYO FAQ
Which is bigger, CVRx or Myomo?
Myomo (MYO) is larger, with a market capitalization of $56.64M compared with $42.09M for CVRx (CVRX).
Which stock has performed better over the past year, CVRX or MYO?
MYO returned +23.28% over the past 12 months, compared with -82.75% for CVRX (price return, excluding dividends). Past performance does not predict future results.
Are CVRx and Myomo in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for CVRx and Industrial Specialties for Myomo.